share_log

Tenax Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Janus Henderson Group plc(10.0%),Janus Henderson Biotech Innovation Master Fund Ltd(10.0%)

Tenax Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Janus Henderson Group plc(10.0%),Janus Henderson Biotech Innovation Master Fund Ltd(10.0%)

美股SEC公告 ·  2024/11/14 11:42
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息